Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; 18 of the 51 sources its claims cite were checked for support.

Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency

Open access
Reid-Bayliss, Kate S., Arron, Sarah T., Loeb, Lawrence A., Bezrookove, Vladimir, Cleaver, James E. · 2016 · Proceedings of the National Academy of Sciences

Abstract

Cockayne syndrome (CS) and xeroderma pigmentosum (XP) are human photosensitive diseases with mutations in the nucleotide excision repair (NER) pathway, which repairs DNA damage from UV exposure. CS is mutated in the transcription-coupled repair (TCR) branch of the NER pathway and exhibits developmental and neurological pathologies. The XP-C group of XP patients have mutations in the global genome repair (GGR) branch of the NER pathway and have a very high incidence of UV-induced skin cancer. Cultured cells from both diseases have similar sensitivity to UV-induced cytotoxicity, but CS patients have never been reported to develop cancer, although they often exhibit photosensitivity. Because cancers are associated with increased mutations, especially when initiated by DNA damage, we examined UV-induced mutagenesis in both XP-C and CS cells, using duplex sequencing for high-sensitivity mutation detection. Duplex sequencing detects rare mutagenic events, independent of selection and in multiple loci, enabling examination of all mutations rather than just those that confer major changes to a specific protein. We found telomerase-positive normal and CS-B cells had increased background mutation frequencies that decreased upon irradiation, purging the population of subclonal variants. Primary XP-C cells had increased UV-induced mutation frequencies compared with normal cells, consistent with their GGR deficiency. CS cells, in contrast, had normal levels of mutagenesis despite their TCR deficiency. The lack of elevated UV-induced mutagenesis in CS cells reveals that their TCR deficiency, although increasing cytotoxicity, is not mutagenic. Therefore the absence of cancer in CS patients results from the absence of UV-induced mutagenesis rather than from enhanced lethality.

Overview

CoChat Summary

TL;DR

Cockayne syndrome (CS) cells are UV-sensitive but do not show elevated UV-induced mutagenesis, unlike xeroderma pigmentosum group C (XP-C) cells. The authors conclude that the absence of cancer in CS patients reflects a lack of increased UV-induced mutations rather than only enhanced lethality.

Key findings

  • XP-C primary fibroblasts showed elevated subclonal UV-specific C:G→T:A mutations at dipyrimidine (Py-Py) sites after UVC, relative to normal fibroblasts, consistent with their global genome repair (GGR) defect and >1,000-fold increased cancer incidence.
  • CS-A and CS-B primary fibroblasts showed no elevation in UV-specific C:G→T:A mutations at Py-Py sites relative to normal fibroblasts, despite similar UVC cytotoxicity; total subclonal mutations initially increased then decreased at higher UVC doses.
  • In CS-B cells, the majority of UV-induced mutations were G:C→T:A, an oxidative-damage signature, rather than the UV-specific C:G→T:A signature.
  • Duplex sequencing detected 39 multiplet mutations; all but one occurred at or directly adjacent to a Py-Py dinucleotide, with CC→TT the most frequent type.

Methods

  • Primary fibroblasts and keratinocytes from normal, XP-C, CS-A, and CS-B donors were exposed to UVC or UVB, cultured 5–7 d, and assayed for survival by MTT; hTERT-immortalized normal and CS-B cells grown ~2 y were also analyzed.
  • One round of duplex sequencing was performed on exonic regions of NRAS, UMPS, PIK3CA, EGFR, BRAF, KRAS, F10, TP53, and TYMS, with a minimum depth of 100 duplex molecules and mid-exon peak depth of 1,000–4,000 duplex molecules.
  • Analyses compared subclonal (<20% clonal) mutation frequencies and spectra, including C:G→T:A at Py-Py sites, oxidative G:C→T:A mutations, gene-expression status, and template versus coding strand distributions.

Limitations

  • The paper states that prior CS mutagenesis studies were limited by few selectable gene loci and possible nonrepresentative episomal vectors, and it notes that further experiments would be necessary to determine whether mutation frequencies are truly lower in CS cells than in normal cells.
  • The paper cautions that hTERT-immortalized cells had high background mutation frequencies, developed aneuploidy and increased copy numbers, and showed UV-induced population bottlenecking, making them problematic for mutagenesis studies.
  • Evident from the text: the conclusions rest on cultured primary cells and cell lines rather than direct cancer incidence in CS patients, and the mutational analyses used a limited number of cell lines per genotype after excluding the anomalous CS-A line GM17536.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.1610020113

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

17 Valid · 2 Not valid · 12 Not checked · 68 Own results and interpretations

62 more claims · 8 with their cited sources checked

Create a free account to see all 99 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 63 references

Research works printed but not linked: 1

  1. AR Lehmann, Cockayne syndrome and trichothiodystrophy: Defective repair without cancer. Cancer Reviews 7, 82–103 (1987).

Cited by

See all 55

Metadata

Authors
Reid-Bayliss, K. S., Arron, S. T., Loeb, L. A., Bezrookove, V., & Cleaver, J. E.
Affiliations
  • University of Washington (US)
  • University of California, San Francisco (US)
  • California Pacific Medical Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2016-08-19
Volume
113
Issue
36
Pages
10151-10156
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2507443637
Cited by
55
References
63
Citations by year
2026: 5 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 5 · 2018: 9 · 2017: 8
FWCI
3.81
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • HHS | NIH | National Cancer Institute (CA181771, CA077852)
  • Academic Senate University of California San Francisco (N/A)
  • Lily Drake Cancer Research Fund,University of San Francisco CA (N/A)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
Cockayne syndrome, xeroderma pigmentosum, nucleotide excision repair, transcription-coupled repair, global genome repair, UV mutagenesis, UV-induced skin cancer, DNA repair deficiency, photosensitivity, duplex sequencing, mutation frequency, subclonal variants
MeSH terms
Cockayne Syndrome, DNA, DNA Repair, Fibroblasts, Humans, Mutation, Skin Neoplasms, Ultraviolet Rays, Xeroderma Pigmentosum, Keratinocytes, Sequence Analysis, DNA, DNA Breaks, Double-Stranded, Primary Cell Culture, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency. https://app.cochat.ai/papers/10.1073/pnas.1610020113
The paper
Reid-Bayliss, K. S., Arron, S. T., Loeb, L. A., Bezrookove, V., & Cleaver, J. E. (2016). Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1610020113

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.